[1] Carey Elizabeth J,Lai Jennifer C, Christopher S,et al. A North American Expert Opinion Statement on Sarcopenia in Liver Transplantation.Hepatology, 2019, 70: 1816-1829.
[2] Berardi G, Antonelli G, Colasanti M,et al. Association of Sarcopenia and Body Composition With Short-term Outcomes After Liver Resection for Malignant Tumors. JAMA Surg,2020,155(11):e203336.
[3] Ebadi M, Tandon P, Moctezuma-Velazquez C,et al. Low subcutaneous adiposity associates with higher mortality in female patients with cirrhosis. J Hepatol,2018,69(3):608-616.
[4] Carey EJ,Lai JC,Wang CW,et al. A multicenter study to define sarcopenia in patients with end-stage liver disease.Liver Transpl,2017,235:625-633.
[5] Benmassaoud A, Roccarina D, Arico F,et al. Sarcopenia Does Not Worsen Survival in Patients With Cirrhosis Undergoing Transjugular Intrahepatic Portosystemic Shunt for Refractory Ascites. Am J Gastroenterol,2020,115(11):1911-1914.
[6] Hong HC, Hwang SY, Choi HY,et al.Relationship between sarcopenia and nonalcoholic fatty liver disease: the Korean Sarcopenic Obesity Study. Hepatology,2014,59(5):1772-1778.
[7] 李侗曾,孔明,宋文艳,等.慢加急性肝衰竭患者第三腰椎骨骼肌指数与临床指标的关系.实用肝脏病杂志,2020,23(04):467-470.
[8] Nishikawa H,Shiraki M,Hiramatsu A,et al. Japan society of hepatology guidelines for sarcopenia in liver disease (1stedition): Recommendation from the working group for reation of sarcopenia assessment criteria. Hepatol Res,2016,46(10):951-963.
[9] Kim G, Lee SE, Lee YB,et al. Relationship Between Relative Skeletal Muscle Mass and Nonalcoholic Fatty Liver Disease: A 7-Year Longitudinal Study. Hepatology,2018,68(5):1755-1768.
[10] Shih KL, Su WW, Chang CC, et al. Comparisons of parallel potential biomarkers of 1H-MRS measured hepatic lipid content in patients with non-alcoholic fatty liver disease. Sci Rep,2016,6:24031.
[11] Kappus MR, Wegermann K, Bozdogan E,et al. Use of Skeletal Muscle Index as a Predictor of Wait-List Mortality in Patients With End-Stage Liver Disease. Liver Transpl,2020,26(9):1090-1099.
[12] Kaido T, Tamai Y, Hamaguchi Y,et al. Effects of pretransplant sarcopenia and sequential changes in sarcopenic parameters after living donor liver transplantation. Nutrition,2017,33:195-198.
[13] Shoreibah MG, Mahmoud K, Aboueldahab NA,et al.Psoas Muscle Density in Combination with Model for End-Stage Liver Disease Score?Can Improve Survival Predictability in Transjugular Intrahepatic Portosystemic?Shunts. J Vasc Interv Radiol,2019,30(2):154-161.
[14] Romagna ES, Appel-da-Silva MC, Suwa E,et al.Muscle depletion in cirrhotic patients assessed using computed tomography: a cross-sectional study. Sao Paulo Med J,2020,138(2):152-157.
[15] Lee SW, Son JY, Kim JM,et al. Body fat distribution is more predictive of all-cause mortality than overall adiposity. Diabetes Obes Metab,2018,20(1):141-147.
[16] Hamaguchi Y, Kaido T, Okumura S,et al.Including body composition in MELD scores improves mortality prediction among patients awaiting liver transplantation. Clin Nutr,2020,39(6):1885-1892.
[17] Kamo N, Kaido T, Hamaguchi Y,et al.Impact of sarcopenic obesity on outcomes in patients undergoing living donor liver transplantation. Clin Nutr,2019,38(5):2202-2209.
[18] Dong QT, Cai HY, Zhang Z,et al.Influence of body composition, muscle strength, and physical performance on the postoperative complications and survival after radical gastrectomy for gastric cancer: A comprehensive analysis from a large-scale prospective study. Clin Nutr,2021,40(5):3360-3369.
[19] Fujiwara N, Nakagawa H, Kudo Y,et al.Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma. J Hepatol,2015,63(1):131-140.
[20] Hamaguchi Y, Kaido T, Okumura S,et al.Preoperative Visceral Adiposity and Muscularity Predict Poor Outcomes after Hepatectomy for Hepatocellular Carcinoma. Liver Cancer,2019,8(2):92-109.
[21] Hamaguchi Y, Kaido T, Okumura S,et al.Proposal for new selection criteria considering pre-transplant muscularity and visceral adiposity in living donor liver transplantation. J Cachexia Sarcopenia Muscle,2018,9(2):246-254.
[22] Lee YH, Jung KS, Kim SU,et al. Sarcopaenia is associated with NAFLD independently of obesity and insulin resistance: Nationwide surveys (KNHANES 2008-2011). J Hepatol,2015,63(2):486-93.
[23] Fujiwara N, Nakagawa H, Kudo Y,et al. Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma. J Hepatol,2015,63(1):131-40.
[24] Macshut M, Kaido T, Yao S,et al.Visceral adiposity is an independent risk factor for high intra-operative blood loss during living-donor liver transplantation; could preoperative rehabilitation and nutritional therapy mitigate that risk? Clin Nutr,2021,40(3):956-965.
[25] Huguet A, Latournerie M, Debry PH,et al.The psoas muscle transversal diameter predicts mortality in patients with cirrhosis on a waiting list for liver transplantation: A retrospective cohort study. Nutrition,2018,51-52:73-79.
[26] 韩芳,肖慧娟,张翔,等.肝硬化及肝细胞癌患者腰肌横向厚度指数与营养风险的相关性分析.临床肝胆病杂志,2020,36(08):1753-1756.
[27] Praktiknjo M, Book M, Luetkens J, et al. Fat-free muscle mass in magnetic resonance imaging predicts acute-on-chronic liver failure and survival in decompensated cirrhosis. Hepatology,2018,67(3):1014-26.
[28] 胡振民,张树生.进行性肌营养不良症的CT诊断:附11例临床及CT分析.中华放射学杂志,1990,24(6):348-350. |
